The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates ChallengesSummaryGBI Research has released its research - 'The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges'. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global pain management therapeutics market. The report analyzes the markets for pain management in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.ScopeThe scope of this report includes:- Annualized market data for the pain management market from 2001 to 2009, forecast forward to 2016.- Analysis of the leading therapeutic segments, including neuropathic pain, osteoarthritis, cancer pain, migraine and fibromyalgia.- Analysis of the pain management market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain and Japan.- Market characterization of the pain management market including market size, the annual cost of therapy, sales volume and treatment usage patterns. - Key drivers and barriers that have a significant impact on the market. - Coverage of pipeline molecules in the various phases of drug development. - Competitive benchmarking of leading companies. The key companies studied in this report are Pfizer, Inc., Eli Lilly and Company, Johnson & Johnson, Novartis AG, Merck & Co Inc., and Cephalon, Inc.- Key M&A activities that have taken place in 2009 and the licensing agreements in the 2008-2009 global pain management market.Reasons to buyThe report will enhance your decision making capability. It will allow you to - Align product portfolio to the markets with high growth potential - Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth - Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety - Develop key strategic initiatives by understanding key focus areas of leading companies - Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
The Future of Pain Management Therapeutics, Analysis and Market
Forecasts to 2016 - Increasing Generic Competition Creates
Challenges
Published on March 2010
Report Summary
The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates
Challenges
Summary
GBI Research has released its research - 'The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 -
Increasing Generic Competition Creates Challenges'. The report provides in-depth analysis of unmet needs, drivers and barriers that
impact the global pain management therapeutics market. The report analyzes the markets for pain management in the US, the top
five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume
are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive
benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global
markets. This report is built using data and information sourced from proprietary databases, primary and secondary research and
in-house analysis by GBI Research's team of industry experts.
Scope
The scope of this report includes:
- Annualized market data for the pain management market from 2001 to 2009, forecast forward to 2016.
- Analysis of the leading therapeutic segments, including neuropathic pain, osteoarthritis, cancer pain, migraine and fibromyalgia.
- Analysis of the pain management market in the leading geographies of the world, which include the US, the UK, Germany, France,
Italy, Spain and Japan.
- Market characterization of the pain management market including market size, the annual cost of therapy, sales volume and
treatment usage patterns.
- Key drivers and barriers that have a significant impact on the market.
- Coverage of pipeline molecules in the various phases of drug development.
- Competitive benchmarking of leading companies. The key companies studied in this report are Pfizer, Inc., Eli Lilly and Company,
Johnson & Johnson, Novartis AG, Merck & Co Inc., and Cephalon, Inc.
- Key M&A activities that have taken place in 2009 and the licensing agreements in the 2008-2009 global pain management market.
Reasons to buy
The report will enhance your decision making capability. It will allow you to
- Align product portfolio to the markets with high growth potential
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets
poised for strong growth
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and
better safety
The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 1/11

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
- Develop key strategic initiatives by understanding key focus areas of leading companies
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps
Table of Content
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 10
2 Global Pain Management Therapeutics Market: Introduction 13
2.1 GBI Research Report Guidance 13
3 Global Pain Management Therapeutics Market: Market Overview 14
3.1 Introduction 14
3.2 Revenue Forecast for the Global Pain Management Therapeutics Market 15
3.2.1 Sales Value 15
3.2.2 Patient Volume 16
3.2.3 Annual Cost of Therapy 17
3.2.4 Treatment Usage Patterns 18
3.2.5 Generics' Share in the Global Pain Management Therapeutics Market 23
3.2.6 Sales of Leading Drugs 24
3.3 Pain Management Therapeutics Market Drivers 25
3.3.1 Increase in Diagnosed and Prescription Population 25
4 Global Pain Management Therapeutics Market: Therapeutic Landscape 26
4.1 Fibromyalgia Market 26
4.1.1 Introduction 26
4.1.2 Sales Value 26
4.1.3 Patient Volume 28
4.1.4 Annual Cost of Therapy 29
4.1.5 Treatment Usage Patterns 30
4.1.6 Drivers for Fibromyalgia Pain Market 35
4.1.7 Restraints for Fibromyalgia Pain Market 36
4.1.8 Unmet Needs 36
4.2 Neuropathic Pain Market 36
4.2.1 Introduction 36
4.2.2 Sales Value 37
4.2.3 Patient Volume 38
4.2.4 Annual Cost of Therapy 39
4.2.5 Treatment Usage Patterns 40
4.2.6 Drivers for Neuropathic Pain Market 45
4.2.7 Restraints for Neuropathic Pain Market 46
4.2.8 Unmet Need 46
4.3 Migraine Market 46
4.3.1 Introduction 46
4.3.2 Sales Value 47
4.3.3 Patient Volume 48
4.3.4 Annual Cost of Therapy 49
4.3.5 Treatment Usage Patterns 50
4.3.6 Drivers for Migraine Market 55
The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 2/11

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
4.3.7 Restraints for Migraine Market 55
4.3.8 Unmet Need 56
4.4 Cancer Pain Market 56
4.4.1 Introduction 56
4.4.2 Sales Value 56
4.4.3 Patient Volume 58
4.4.4 Annual Cost of Therapy 59
4.4.5 Treatment Usage Patterns 60
4.4.6 Drivers for Cancer Pain Market 64
4.4.7 Restraints for Cancer Pain Market 65
4.4.8 Unmet Need 65
4.5 Osteoarthritis Pain Market 65
4.5.1 Introduction 65
4.5.2 Sales Value 66
4.5.3 Patient Volume 67
4.5.4 Annual Cost of Therapy 68
4.5.5 Treatment Usage Patterns 69
4.5.6 Drivers for Osteoarthritis Pain Market 73
4.5.7 Restraints for Osteoarthritis Pain Market 74
4.5.8 Unmet Need 74
5 Global Pain Management Therapeutics Market: Geographical Landscape 75
5.1 Geographical Break-up 75
5.2 The US 77
5.2.1 Sales Value 77
5.2.2 Patient Volume 78
5.2.3 Annual Cost of Therapy 79
5.2.4 Treatment Usage Patterns 80
5.3 Top Five Countries in Europe 85
5.3.1 Sales Value 85
5.3.2 Patient Volume 86
5.3.3 Annual Cost of Therapy 87
5.3.4 Treatment Usage Patterns 88
5.4 Japan 93
5.4.1 Sales Value 93
5.4.2 Patient Volume 94
5.4.3 Annual Cost of Therapy 95
5.4.4 Treatment Usage Patterns 96
6 Global Pain Management Therapeutics Market: Pipeline Analysis 102
6.1 Introduction 102
6.1.1 Research and Development Pipeline ' Fibromyalgia 103
6.1.2 Research and Development Pipeline ' Neuropathic Pain 104
6.1.3 Research and Development Pipeline ' Migraine 105
6.1.4 Research and Development Pipeline ' Cancer Pain 106
6.1.5 Research and Development Pipeline ' Osteoarthritis Pain 106
6.2 Profiles of Key Late-Stage Drugs in the Pain Management Market 107
6.2.1 Droxopida 107
6.2.2 Xyrem 107
6.2.3 Vimpat (lacosamide) 107
6.2.4 Qutenza (capsaicin 8%) 108
6.2.5 Botox 109
The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 3/11

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
6.2.6 Tezampanel 110
6.2.7 Nasalfent 110
6.2.8 PF-4383119 (Tanezumab) 111
7 Global Pain Management Therapeutics Market: Competitive Landscape 112
7.1 Market Share Analysis 112
7.2 Competitive Profiling 112
7.2.1 Pfizer, Inc. 114
7.2.2 Eli Lilly and Company 115
7.2.3 Johnson & Johnson 117
7.2.4 Endo Pharmaceuticals 119
7.2.5 Novartis AG 120
7.2.6 Merck & Co Inc 122
7.2.7 Cephalon, Inc. 123
8 Global Pain Management Therapeutics Market: Strategic Consolidations 125
8.1 Overview 125
8.1.1 Sanofi-Aventis Acquired 100% outstanding shares of Chattem, Inc in December 2009 127
8.1.2 Dainippon Sumitomo Pharma Acquired Sepracor, Inc. in October 2009 127
8.1.3 Raptor Pharmaceuticals and TorreyPines Therapeutics Merged in August 2009 127
8.1.4 Alexza Pharmaceuticals Acquired Symphony Allegro in June 2009 127
8.1.5 Anesiva and Arcion Therapeutics Merge in May 2009 127
8.1.6 Mylan Laboratories Acquired Matrix Laboratories Limited in March 2009 128
8.2 R&D Licensing Agreements 128
8.2.1 Deals by Indication 128
8.2.2 Deals by Phase 129
8.2.3 Deals by Geography 130
8.2.4 Deals by Value ($) 131
8.2.5 Preclinical and Discovery 131
8.2.6 Phase I 132
8.2.7 Phase II 132
8.2.8 Phase III 133
8.2.9 Approved and Regulatory Filing 134
9 Global Pain Management Therapeutics Market: Appendix 136
9.1 Market Definitions 136
9.2 Abbreviations 136
9.3 Research Methodology 137
9.3.1 Coverage 137
9.3.2 Secondary Research 138
9.3.3 Primary Research 138
9.3.4 Forecasts 138
9.3.5 Expert Panel Validation 140
9.4 Contact Us 141
9.5 Disclaimer 141
9.6 Sources 141
1.1 List of Tables
Table 1: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2001-2009 16
Table 2: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2009-2016 16
Table 3: Pain Management Therapeutics Market, Global, Patient Volume (Millions), 2001-2009 17
Table 4: Pain Management Therapeutics Market, Global, Patient Volume (Millions), 2009-2016 17
Table 5: Pain Management Therapeutics Market, Global, Annual Average Cost of Therapy ($), 2001-2009 18
Table 6: Pain Management Therapeutics Market, Global, Annual Average Cost of Therapy ($), 2009-2016 18
The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 4/11

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Table 7: Pain Management Therapeutics Market, Global, Treatment Usage Patterns, 2001-2009 19
Table 8: Pain Management Therapeutics Market, Global, Treatment Usage Patterns, 2009-2016 20
Table 9: Pain Management Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($m), 2009-2016 24
Table 10: Pain Management Therapeutics Market, Global, Sales of Leading Drugs, 2009 25
Table 11: Pain Management Therapeutics Market, Global, Fibromyalgia Sales Value ($m), 2001-2009 28
Table 12: Pain Management Therapeutics Market, Global, Fibromyalgia Sales Value ($m), 2009-2016 28
Table 13: Pain Management Therapeutics Market, Global, Fibromyalgia, Patient Volume (Millions), 2001-2009 29
Table 14: Pain Management Therapeutics Market, Global, Fibromyalgia, Patient Volume (Millions), 2009-2016 29
Table 15: Pain Management Therapeutics Market, Global, Fibromyalgia, Annual Cost of Therapy ($), 2001-2009 30
Table 16: T Pain Management Therapeutics Market, Global, Fibromyalgia, Annual Cost of Therapy ($), 2009-2016 30
Table 17: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Usage Patterns, 2001-2009 32
Table 18: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Usage Patterns, 2009-2016 32
Table 19: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Sales Value ($bn), 2001-2009 38
Table 20: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Sales Value ($bn), 2009-2016 38
Table 21: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Patient Volume (Millions), 2001-2009 39
Table 22: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Patient Volume (Millions), 2009-2016 39
Table 23: Pain Management Therapeutics Market, Global, Neuropathic Pain, Annual Cost of Treatment ($), 2001-2009 40
Table 24: Pain Management Therapeutics Market, Global, Neuropathic Pain, Annual Cost of Treatment ($), 2009-2016 40
Table 25: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Usage Patterns, 2001-2009 41
Table 26: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Usage Patterns, 2009-2016 42
Table 27: Pain Management Therapeutics Market, Global, Migraine Sales Value ($ bn), 2001-2009 48
Table 28: Pain Management Therapeutics Market, Global, Migraine Diseases Population ($ bn), 2009-2016 48
Table 29: Pain Management Therapeutics Market, Global, Migraine Market Patient Volume (Millions), 2001-2009 49
Table 30: Pain Management Therapeutics Market, Global, Migraine Market Patient Volume (Millions), 2009-2016 49
Table 31: Pain Management Therapeutics Market, Global, Migraine, Annual Cost of Therapy ($), 2001-2009 50
Table 32: Pain Management Therapeutics Market, Global, Annual Cost of Migraine Treatment ($), 2001-2009 50
Table 33: Pain Management Therapeutics Market, Global, Migraine Treatment Usage Patterns (Millions), 2001-2009 52
Table 34: Pain Management Therapeutics Market, Global, Migraine Treatment Usage Patterns (Millions), 2009-2016 52
Table 35: Pain Management Therapeutics Market, Global, Cancer Pain Diseases Population ($ bn), 2001-2009 58
Table 36: Pain Management Therapeutics Market, Global, Cancer Pain Diseases Population ($ bn), 2009-2016 58
Table 37: Pain Management Therapeutics Market, Global, Cancer Pain Market Patient Volume (Millions), 2001-2009 59
Table 38: Pain Management Therapeutics Market, Global, Cancer Pain Market Patient Volume (Millions), 2009-2016 59
Table 39: Pain Management Therapeutics Market, Global, Cancer Pain, Annual Cost of Therapy ($), 2001-2009 60
Table 40: Pain Management Therapeutics Market, Global, Cancer Pain, Annual Cost of Therapy ($), 2009-2016 60
Table 41: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Usage Patterns (millions), 2001-2009 61
Table 42: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Usage Patterns (millions), 2009-2016 62
Table 43: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Sales Value ($bn), 2001-2009 67
Table 44: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Sales Value ($bn), 2009-2016 67
Table 45: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Market Patient Volume (million), 2001-2009 68
Table 46: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Market Patient Volume (million), 2009-2016 68
Table 47: Pain Management Therapeutics Market, Global, of Osteoarthritis Pain, Annual Cost of Therapy ($), 2001-2009 69
Table 48: Pain Management Therapeutics Market, Global, of Osteoarthritis Pain, Annual Cost of Therapy ($), 2009-2016 69
Table 49: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Usage Patterns (million), 2001-2009 70
Table 50: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Usage Patterns (million), 2009-2016 71
Table 51: Pain Management Therapeutics Market, Global, Sales Value by Geography ($ bn), 2001-2009 77
Table 52: Pain Management Therapeutics Market, Global, Sales Value by Geography ($ bn), 2009-2016 77
Table 53: Pain Management Therapeutics Market, US, Sales Value ($ bn), 2001-2009 78
Table 54: Pain Management Therapeutics Market, US, Sales Value ($ bn), 2009-2016 78
Table 55: Pain Management Therapeutics Market, US, Patient Volume (million), 2001-2009 79
Table 56: Pain Management Therapeutics Market, US, Patient Volume (million), 2009-2016 79
The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 5/11

6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Table 57: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2001-2009 80
Table 58: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2009-2016 80
Table 59: Pain Management Therapeutics Market, the US, Treatment Usage Patterns (million), 2001-2009 81
Table 60: Pain Management Therapeutics Market, the US, Treatment Usage Patterns (million), 2009-2016 82
Table 61: Pain Management Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2001-2009 86
Table 62: Pain Management Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2009-2016 86
Table 63: Pain Management Therapeutics Market, Top Five Countries in Europe, Patient Volume (million), 2001-2009 87
Table 64: Pain Management Therapeutics Market, Top Five Countries in Europe, Patient Volume (million), 2009-2016 87
Table 65: Pain Management Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2001-2009 88
Table 66: Pain Management Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2009-2016 88
Table 67: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns (Millions), 2001-2009 89
Table 68: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns (Millions), 2009-2016 90
Table 69: Pain Management Therapeutics Market, Japan, Sales Value ($ bn), 2001-2009 94
Table 70: Pain Management Therapeutics Market, Japan, Sales Value ($ bn), 2009-2016 94
Table 71: Pain Management Therapeutics Market, Japan, Patient Volume (million), 2001-2009 95
Table 72: Pain Management Therapeutics Market, Japan, Patient Volume (million), 2009-2016 95
Table 73: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($), 2001-2009 96
Table 74: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($), 2009-2016 96
Table 75: Pain Management Therapeutics Market, Japan, Treatment Usage Patterns (Millions), 2001-2009 98
Table 76: Pain Management Therapeutics Market, Japan, Treatment Usage Patterns (Millions) , 2009-2016 98
Table 77: Pain Management Therapeutics Market, Global, Competitive Landscape, 2009 114
Table 78: Pain Management Therapeutics Market, Merck, Pipeline Products, December 2009 116
Table 79: Pain Management Therapeutics Market, Eli Lilly, Pipeline Products, 2010 117
Table 80: Pain Management Therapeutics Market, J&J, Pipeline Products, 2010 120
Table 81: Pain Management Therapeutics Market, Endo Pharmaceuticals, Pipeline Products, 2010 121
Table 82: Pain Management Therapeutics Market, Novartis, Pipeline Products, 2010 123
Table 83: Pain Management Therapeutics Market, Merck & Co, Inc., Pipeline Products, 2010 124
Table 84: Cephalon Inc. ' Pain Pipeline Products, 2009 125
Table 85: Pain Management Therapeutics Market, Global, Major M&A Deals, 2009-2010 127
Table 86: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in the Preclinical Stage, 2008-2009 132
Table 87: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in Phase I, 2008-2009 133
Table 88: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in Phase II, 2008-2009 133
Table 89: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in Phase III, 2008-2009 134
Table 90: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs Which are Approved or Awaiting
Approval, 2008-2009 135
1.2 List of Figures
Figure 1: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2000-2016 15
Figure 2: Pain Management Therapeutics Market, Global, Volume (Millions), 2001-2016 16
Figure 3: Pain Management Therapeutics Market, Global, Annual Cost of Therapy ($),
2000-2015 17
Figure 4: Pain Management Therapeutics Market, Global, Treatment Usage Patterns, 2000-2015 18
Figure 5: Pain Management Therapeutics Market, Global, Diseased Population (Millions),
2001-2016 19
Figure 6: Pain Management Therapeutics Market, Global, Treatment Seeking Population (Millions), 2001-2016 20
Figure 7: Pain Management Therapeutics Market, Global, Diagnosed Population (Millions), 2001-2016 21
Figure 8: Pain Management Therapeutics Market, Global, Prescription Population (Millions), 2001-2016 22
Figure 9: Pain Management Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($m), 2009-2016 23
Figure 10: Pain Management Therapeutics Market, Global, Growth Parameters, 2009 25
Figure 11: Pain Management Therapeutics Market, Global, Sales Value by Indication (%) 2009 and 2016 26
Figure 12: Pain Management Therapeutics Market, Global, Fibromyalgia Sales Value ($ bn), 2001-2016 27
The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 6/11

7. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Figure 13: Pain Management Therapeutics Market, Global, Fibromyalgia, Patient Volume (Millions), 2001-2016 28
Figure 14: Pain Management Therapeutics Market, Global, Fibromyalgia, Annual Cost of Therapy ($), 2001-2016 29
Figure 15: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Usage Patterns, 2001-2009 30
Figure 16: Pain Management Therapeutics Market, Global, Fibromyalgia Diseased Population (Millions), 2001-2016 32
Figure 17: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Seeking Population (Millions), 2001-2016 33
Figure 18: Pain Management Therapeutics Market, Global, Fibromyalgia Diagnosed Population (Millions), 2001-2016 34
Figure 19: Pain Management Therapeutics Market, Global, Fibromyalgia Prescription Population (Millions), 2001-2016 35
Figure 20: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2001-2016 37
Figure 21: Pain Management Therapeutics Market, Global, Neuropathic Pain, Patient Volume (Millions), 2001-2016 38
Figure 22: Pain Management Therapeutics Market, Global, Neuropathic Pain, Annual Cost of Therapy ($), 2001-2016 39
Figure 23: Pain Management Therapeutics Market, Global, Neuropathic Treatment Usage Patterns, 2001-2016 40
Figure 24: Pain Management Therapeutics Market, Global, Neuropathic Pain Diseased Population (Millions), 2001-2016 42
Figure 25: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Seeking Population (Millions), 2001-2016 43
Figure 26: Pain Management Therapeutics Market, Global, Neuropathic Pain Diagnosed Population (Millions), 2001-2016 44
Figure 27: Pain Management Therapeutics Market, Global, Neuropathic Pain Prescription Population (Millions), 2001-2016 45
Figure 28: Pain Management Therapeutics Market, Global, Migraine Sales Value ($ bn),
2001-2016 47
Figure 29: Pain Management Therapeutics Market, Global, Migraine Market Patient Volume (Millions), 2001-2016 48
Figure 30: Pain Management Therapeutics Market, Global, Migraine, Annual Cost of Therapy ($), 2001-2016 49
Figure 31: Pain Management Therapeutics Market, Global, Migraine Treatment Usage Patterns (Millions) , 2001-2016 50
Figure 32: Pain Management Therapeutics Market, Global, Migraine Diseased Population (Millions), 2001-2016 52
Figure 33: Pain Management Therapeutics Market, Global, Migraine Treatment Seeking Population (Millions), 2001-2016 53
Figure 34: Pain Management Therapeutics Market, Global, Migraine Diagnosed Population (Millions), 2001-2016 54
Figure 35: Pain Management Therapeutics Market, Global, Migraine Prescription Population (Millions), 2001-2016 55
Figure 36: Pain Management Therapeutics Market, Global, Cancer Pain Sales Value ($ bn),
2001-2016 57
Figure 37: Pain Management Therapeutics Market, Global, Cancer Pain Market Patient Volume (Millions), 2001-2016 58
Figure 38: Pain Management Therapeutics Market, Global, Cancer Pain, Annual Cost of Therapy ($), 2001-2016 59
Figure 39: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Usage Patterns, 2001-2016 60
Figure 40: Pain Management Therapeutics Market, Global, Cancer Pain Diseased Population, 2001-2016 61
Figure 41: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Seeking Population, 2001-2016 62
Figure 42: Pain Management Therapeutics Market, Global, Cancer Pain Diagnosed Population, 2001-2016 63
Figure 43: Pain Management Therapeutics Market, Global, Cancer Pain Prescription Population, 2001-2016 64
Figure 44: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Sales Value ($ bn), 2001-2016 66
Figure 45: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Market Patient Volume (Millions), 2001-2016 67
Figure 46: Pain Management Therapeutics Market, Global, of Osteoarthritis Pain, Annual Cost of Therapy ($), 2001-2016 68
Figure 47: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Usage Patterns, 2001-2016 69
Figure 48: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Diseased Population, 2001-2016 70
Figure 49: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Seeking Population, 2001-2016 71
Figure 50: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Diagnosed Population, 2001-2016 72
Figure 51: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Prescription Population, 2001-2016 73
Figure 52: Pain Management Therapeutics Market, Global, Market Share by Geography, 2009 and 2016 75
Figure 53: Pain Management Therapeutics Market, Global, Sales Value by Geography ($bn), 2001-2016 76
Figure 54: Pain Management Therapeutics Market, US, Sales Value ($ bn), 2001-2016 77
Figure 55: Pain Management Therapeutics Market, US, Patient Volume (million), 2001-2016 78
Figure 56: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2001-2016 79
Figure 57: Pain Management Therapeutics Market, US, Treatment Usage Patterns, 2001-2016 80
Figure 58: Pain Management Therapeutics Market, US, Diseased Population (Millions),
2001-2016 81
Figure 59: Pain Management Therapeutics Market, US, Treatment Seeking Population (Millions), 2001-2016 82
The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 7/11

8. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Figure 60: Pain Management Therapeutics Market, US, Diagnosed Population (Millions),
2001-2016 83
Figure 61: Pain Management Therapeutics Market, US, Prescription Population (Millions),
2001-2016 84
Figure 62: Pain Management Therapeutics Market, Top Five Countries in Europe, Sales Value
($ bn), 2001-2016 85
Figure 63: Pain Management Therapeutics Market, Top Five Countries in Europe, Patient Volume (million), 2001-2016 86
Figure 64: Pain Management Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2001-2016 87
Figure 65,: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns (Millions), 2001-2016
88
Figure 66: Pain Management Therapeutics Market, Top Five Countries in Europe, Diseased Population (Millions), 2001-2016 89
Figure 67: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Seeking Population (Millions),
2001-2016 90
Figure 68: Pain Management Therapeutics Market, Top Five Countries in Europe, Diagnosed Population (Millions), 2001-2016 91
Figure 69: Pain Management Therapeutics Market, Top Five Countries in Europe, Prescription Population (Millions), 2001-2016 92
Figure 70: Pain Management Therapeutics Market, Japan, Sales Value ($ bn), 2001-2016 93
Figure 71: Pain Management Therapeutics Market, Japan, Patient Volume (million) , 2001-2016 94
Figure 72: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($),
2001-2016 95
Figure 73: Pain Management Therapeutics Market, Japan, Treatment Usage Patterns (Millions), 2001-2016 96
Figure 74: Pain Management Therapeutics Market, Japan, Diseased Population (Millions),
2001-2016 98
Figure 75: Pain Management Therapeutics Market, Japan, Treatment Seeking Population (Millions), 2001-2016 99
Figure 76: Pain Management Therapeutics Market, Japan, Diagnosed Population (Millions),
2001-2016 100
Figure 77: Pain Management Therapeutics Market, Japan, Prescription Population (Millions), 2001-2016 101
Figure 78: Pain Management Therapeutics Market, Global, R&D Pipeline by Indication, December 2009 102
Figure 79: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase, December 2009 102
Figure 80: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Fibromyalgia, March 2010 103
Figure 81: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Neuropathic Pain, March 2010 104
Figure 82: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Migraine, March 2010 105
Figure 83: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Cancer Pain, March 2010 106
Figure 84: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Osteoarthritis, March 2010 106
Figure 85: Pain Management Therapeutics Market, Global, Market Share of Top Manufacturers, 2009 112
Figure 86: Pain Management Therapeutics Market, Global, Pfizer, Share of Key Pain Drugs Revenue, 2009 114
Figure 87: Pain Management Therapeutics Market, Global, Eli Lilly and Company, Share of Key Pain Drugs Revenue, 2009 116
Figure 88: Pain Management Therapeutics Market, Global, Johnson & Johnson, Share of Key Pain Drugs Revenue, 2009 118
Figure 89: Pain Management Therapeutics Market, Global, Endo Pharmaceuticals, Share of Key Pain Drugs Revenue, 2009 119
Figure 90: Pain Management Therapeutics Market, Global, Novartis, Share of Key Pain Drugs Revenue, 2009 121
Figure 91: Pain Management Therapeutics Market, Global, Merck & Co, Inc., Share of Key Pain Drugs Revenue, 2009 123
Figure 92: Pain Management Therapeutics Market, Global,Cephalon, Share of Key Pain Drugs Revenue, 2009 124
Figure 93: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Indication, 2008-2010 128
Figure 94: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Phase, 2008-2010 129
Figure 95: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Geography, 2008-2010 130
Figure 96: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Value, 2008-2010, n=8 131
Figure 97: GBI Research Methodology, 2010 137
Figure 98: GBI Research Market Forecasting Model, 2010 140
Companies mentioned
Pfizer, Inc.
The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 8/11

9. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Eli Lilly and Company
Johnson & Johnson
Endo Pharmaceuticals
Novartis AG
Merck & Co Inc
Cephalon, Inc.
The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 9/11

10. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competi
tion Creates Challenges
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 3 500.00 Quantity: _____
Site License--USD 7 000.00 Quantity: _____
Corporate License--USD 10 500.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 10/11

11. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 11/11